A-A-0051816A(DM)
16 February 1988
SUPERSEDING
A-A-0051816(DM)
2 February 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
POLYTHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Material, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be a powder consisting of one of the following formulas which, when reconstituted as directed in the labeling procedures as isosmotic (with respect to colon contents) solution for oral administration:
For Type I, the powder shall consist of the following formula:
|
Polyethylene glycol 3350 |
236 to 240 grams |
|
Potassium chloride |
2.9 to 3.0 grams |
|
Sodium bicarbonate |
6.7 to 6.75 grams |
|
Sodium chloride |
5.8 to 5.9 grams |
|
Sodium sulfate |
21.7 to 22.75 grams |
For Type II, the powder shall consist of the following formula:
|
Polyethylene glycol 3350 |
240 grams |
|
Potassium chloride |
2.98 grams |
|
Sodium bicarbonate |
6.72 grams |
|
Sodium chloride |
5.84 |
|
Sodium sulfate |
22.72 grams |
Shall contain the required amounts of the ingredients in the formula within the applicable assay limits as determined from the batch formulation sheet kept on file by the manufacturer.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business